Eledon Pharmaceuticals (ELDN) Cash from Operations (2013 - 2026)
Eledon Pharmaceuticals (ELDN) posted Cash from Operations of 22612000.0 for Q1 2026, down 60.47% on a QoQ basis from 14091000.0 in Q4 2025, and down 40.8% year-over-year from 38194017.67 in Q1 2025.
Eledon Pharmaceuticals (ELDN) Cash from Operations (2013 - 2026) Analysis & Trends
Eledon Pharmaceuticals' Cash from Operations history runs 14 years deep, the most recent figure standing at 22612000.0 for Q1 2026.
- Quarterly Cash from Operations fell 40.8% year-over-year to 22612000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 68893000.0 (down 26.2% YoY) and the FY2025 annual result came in at 62341000.0, down 31.88% from the prior year.
- Cash from Operations was 22612000.0 for Q1 2026 at Eledon Pharmaceuticals, down from 14091000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 4571000.0 in Q3 2022 and bottomed at 22612000.0 in Q1 2026.
- A 5-year average of 11775000.0 and a median of 9924000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations jumped 35.56% — and 2023, when it tumbled 168.02%.
- Eledon Pharmaceuticals' Cash from Operations stood at 9480000.0 in 2022, then advanced by 3.68% to 9131000.0 in 2023, then slumped by 107.94% to 18987000.0 in 2024, then rose by 25.79% to 14091000.0 in 2025, then sank by 60.47% to 22612000.0 in 2026.
- Business Quant data shows ELDN's Cash from Operations at 22612000.0 in Q1 2026, 14091000.0 in Q4 2025, and 14477000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 201.34 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.17 Mn |
| 10 | Eledon Pharmaceuticals | 399.11 Mn | 399.11 Mn | - | -22.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.61 Mn |
| Mar 31, 2026 | -22.61 Mn |
| Dec 31, 2025 | -14.09 Mn |
| Dec 31, 2025 | -14.09 Mn |
| Sep 30, 2025 | -14.48 Mn |
| Sep 30, 2025 | -14.48 Mn |
| Jun 30, 2025 | -17.71 Mn |
| Jun 30, 2025 | -17.71 Mn |
| Mar 31, 2025 | -16.06 Mn |
| Mar 31, 2025 | -16.06 Mn |
| Dec 31, 2024 | -18.99 Mn |
| Dec 31, 2024 | -18.99 Mn |
| Sep 30, 2024 | -11.77 Mn |
| Sep 30, 2024 | -11.77 Mn |
| Jun 30, 2024 | -7.77 Mn |
| Jun 30, 2024 | -7.77 Mn |
| Mar 31, 2024 | -8.74 Mn |
| Mar 31, 2024 | -8.74 Mn |
| Dec 31, 2023 | -9.13 Mn |
| Dec 31, 2023 | -9.13 Mn |